Radiation Induced Lymphopenia Is Associated With the Effective Dose to the Circulating Immune Cells in Breast Cancer.
Hui, Timothy S K
Kong, Feng-Ming Spring
JournalFrontiers in Oncology
PublisherFrontiers Media S.A.
MetadataShow full item record
AbstractA total of 735 patients were eligible. The mean post/preRT PLC ratio was 0.66 (95% CI: 0.64-0.68) and mean EDIC of breast cancer was 1.70Gy (95% CI: 1.64-1.75). Both post/preRT PLC ratio and postRT PLC were significantly correlated with EDIC (P<0.001), with R2 of 0.246. For patients with normal preRT PLC, the post/preRT PLC ratio was better associated with EDIC, and postRT PLC was expressed as PLC preRT × (0.89 - 0.16 × EDIC). For patients with preRT lymphopenia, postRT PLC was better associated with EDIC and it was 1.1 - 0.17 × EDIC. Using binned EDIC as the dose variable, the bootstrap validated NTCPs fit the data nicely with R2 of 0.93, 0.96, and 0.94 for grade-1, grade-2, and grade-3 RIL, respectively. The corresponding EDIC to induce 50% of grade-1, grade-2 and grade-3 RIL was 1.2, 2.1 and 3.7 Gy, respectively.
Data AvailibilityThe raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
Rights/TermsCopyright © 2022 Chen, Jin, Hui, Jing, Zhang, Nong, Han, Wang, Ma, Yi, Chen, Zhang, Fu, Yang, Xu and Kong.
effective dose to the circulating immune cells (EDIC)
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/18987
- The impact of the effective dose to immune cells on lymphopenia and survival of esophageal cancer after chemoradiotherapy.
- Authors: Xu C, Jin JY, Zhang M, Liu A, Wang J, Mohan R, Kong FS, Lin SH
- Issue date: 2020 May
- Risk factors for radiation induced lymphopenia in patients with breast cancer receiving adjuvant radiotherapy.
- Authors: Chen F, Yu H, Zhang H, Nong Y, Wang Q, Jing H, Han Y, Wu J, Zhou Z, Yang L, Xu Z, Liu Y, Fu P, Jin JY, Hsue V, Chang A, Kong FS
- Issue date: 2021 Aug
- Chemotherapy is a risk factor of lymphopenia before adjuvant radiotherapy in breast cancer.
- Authors: Chen F, Ma L, Wang Q, Zhou M, Nong Y, Jing H, Han Y, Liu Y, Hu Y, Yu H, Fu P, Kong FS
- Issue date: 2022 Jul
- Lymphopenia and Radiation Dose to Circulating Lymphocytes With Neoadjuvant Chemoradiation in Esophageal Squamous Cell Carcinoma.
- Authors: So TH, Chan SK, Chan WL, Choi H, Chiang CL, Lee V, Lam TC, Wong I, Law S, Kwong D, Ming Spring Kong F, Jin JY, Lam KO
- Issue date: 2020 Sep-Oct
- Radiation-Induced Lymphopenia Predicts Poorer Prognosis in Patients With Breast Cancer: A Post Hoc Analysis of a Randomized Controlled Trial of Postmastectomy Hypofractionated Radiation Therapy.
- Authors: Sun GY, Wang SL, Song YW, Jin J, Wang WH, Liu YP, Ren H, Fang H, Tang Y, Zhao XR, Song YC, Yu ZH, Liu XF, Li YX
- Issue date: 2020 Sep 1